Tag: Asklepios BioPharmaceutical

Bayer announces start of Phase 2 GenePHIT trial for AB-1002

businessnewstoday- February 17, 2024

Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

pharmanewsdaily- October 26, 2020

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio ... Read More